, Tracking Stock Market Picks
Enter Symbol:
Idenix Pharmaceuticals, Inc. (IDIX) [hlAlert]

up 620.58 %

Idenix Pharmaceuticals, Inc. (IDIX) rated Overweight with price target $8 by Thomas Weisel

Posted on: Friday,  Jun 12, 2009  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) on 06/12/2009, when the stock price was $3.40. Since
then, Idenix Pharmaceuticals, Inc. has gained 620.59% as of 08/05/2014's recent price of $24.50.
If you would have followed this Thomas Weisel's recommendation on IDIX, you would have gained 620.58% of your investment in 1880 days.

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/12/2009 8:25 AM Buy
3.40 8.00
as of 12/31/2009
1 Week up  120.65 %
1 Month up  151.33 %
3 Months up  52.10 %
1 YTD up  38.23 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy